Professor of medical microbiology
Professor Fielder is the director of Kingston University's Medical, Veterinary and Food Microbiology Research Group, based in the Faculty of Science, Engineering and Computing. His current research encompasses medical, veterinary and food microbiology, including the molecular epidemiology of clinical strains of Staphylococcus aureus (including MRSA and MSSA) and Mycoplasmas, drug resistance and work on the disinfection and decontamination of surfaces in the clinical setting.
Professor Fielder obtained his PhD from King's College London in 1995, where he worked on the bacterial causes of arthritis. He is an accomplished media commentator and science communicator and is currently Honorary General Secretary of the Society for Applied Microbiology.
|1995||PhD in Infection and Immunity, King's College London.|
|1992||BSc in Microbiology, King's College London.|
|1998 -||Reader in medical microbiology, School of Life Sciences, Kingston University. Director of the university's Veterinary, Food and Microbiology Research Group.|
|1995 - 1998||Postdoctoral scientist, Centre for Infection, St.George's University of London.|
Gould SWJ, Fielder MD, Kelly AF, El Sankary W, Naughton DP. (2009) Anti-microbial activities of pomegranate extracts: enhancement by cupric and ferrous salts with vitamin C against multi-drug esistant clinical isolates of Pseudomonas aeruginosa. British Journal of Biomedical Science. In Press.
Mboto CI., Fielder MD., Davies-Russell A., Jewell AP. (2009) HCV prevalence and serotpyes associated with HIV in the Gambia . East African Journal of Medicine. MS-06-80 In Press.
Mboto CI, Fielder MD, Davies AJ, Jewell AP. (2009) Co-infection with HIV and Hepatitis C in the Gambia. West African Journal of Medicine. Vol. 28, No. 1: 304-7.
Gould SWJ, Chadwick M, Cuschieri P, Easmon S, Richardson AC, Price RG, Fielder MD. (2009) The evaluation of novel chromogenic substrates for the detection of lipolytic activity in clinical isolates of Staphylococcus aureus and MRSA from two European study groups. FEMS Microbiol Lett. 2009 May 16.
Gould SWJ, Fielder MD, Kelly AF, Naughton DP. (2009). Anti-microbial activities of pomegranate rind extracts: enhancement by cupric salts against clinical isolates of S. aureus, MRSA and PVL positive CA-MSSA. BMC Complementary and Alternative Medicine; 9:23.
Rashid T, Ebringer A, Tiwana H, Fielder M.(2009). Role of Klebsiella and collagens in Crohn's disease: a new prospect in the use of low-starch diet. Eur J Gastroenterol Hepatol. 21(8):843-9
Fielder MD, Borrielo P. (2009). Zoonosis past, present and future. Microbiologist.10(1): 24-28.
•6. Thompson IR, Bidgood P, Petróczi A, Denholm-Price JCW, Fielder MD. (2009). An alternative methodology for the prediction of adherence to anti HIV treatment. AIDS Res Ther. Jun 1;6(1):9.
Afshar B, Nicholas RAJ, Pitcher D, Fielder MD, Miles, R.J. (2009) Biochemical and genetic variation in Mycoplasma fermentans strains from cell line, human and animal sources. Journal of Applied Microbiology. 107(2):498-505.
Gould SWJ, Fielder MD, Kelly AF, Morgan M, Kenny J, Naughton DP (2009). The antimicrobial properties of copper surfaces against a range of important nosocomial pathogens. Annals of Microbiology . 59 (1) 151-156.
McCarrell EM, Gould SW, Fielder MD, Kelly AF, El Sankary W, Naughton DP.Antimicrobial activities of pomegranate rind extracts: enhancement by addition of metal salts and vitamin C. BMC Complement Altern Med. 2008 Dec 15;8(1):64.
Thompson IR, Bidgood P, Petróczi A, Denholm-Price JCW, Fielder MD. (2008). Statistical analysis of HIV patient data from central Europe: lessons from a three centre study. European Infectious Disease. Vol 2(1)52-57
Gould SWJ, Rollason J, Hilton AC, Cuschieri P, Easmon S, Fielder MD. (2008) Novel demonstration of UK epidemic strains of MRSA in Maltese clinical isolates. Journal of Medical Microbiology. Nov;57(Pt 11):1394-8.
Stokes DJ, Kelly AF, Gould SWJ, Cassar CA, Fielder MD. (2008) The withdrawal of antimicrobial treatment as a mechanism for defeating resistant micro-organisms. FEMS Immunol and Medical Micro Aug;53(3):300-5.
Patel H, Mackintosh D, Ayling RD, Nicholas RAJ, Fielder MD. (2008) A novel medium devoid of ruminant peptone for high yield growth of Mycoplasma ovipneumoniae. Vet Microbiol 127(3-4):309-14. Epub online
Coffils M, Jones LA, Jewell AP, Fielder MD. (2007) The induction of oxidative DNA damage by Helicobacter pylori in HT29 cells. Brit J Biomed Sci 64(4):149-52.
Mboto CI, Fielder MD, Russell AJ, Jewell AP. (2007) CD4+values in individuals infected with HIV and/or co-infected with HCV in The Gambia. Immunology 120 (Suppl 1):79.
Fielder MD. MRSA - an emerging zoonotic agent or a pathogen in edible clothing? (2007) (Published online 17th Jan) http://www.medvetnet.org/cms/templates/doc.php?id=106 Open Access.
Ebringer A, Rashid T, Wilson C, Ptaszynska T, Fielder M. (2006) Ankylosing spondylitis, HLA-B27 and Klebsiella - An overview: Proposal for early diagnosis and treatment. Curr Rheum Rev 2:55-68.
Mboto CI, Davies-Russell A, Fielder M, Jewell AP. (2006). Human Immunodeficiency virus and Hepatitis C co-infection in Subsaharan West Africa. Br J Biomed Sci 63(1): 29-37
Mboto CI, Davies-Russell A, Fielder M, Jewell AP. (2005) Hepatocellular Carcinoma in The Gambia and the role of Hepatitis B and Hepatitis C. Int Semin Surg Oncol 2:20.
Mboto CI, Davies-Russell A, Fielder M, Jewell AP. (2005) Hepatitis C antibodies in asymptomatic first-time blood donors in The Gambia: prevalence and risk factors. Br J Biomed Sci 62(2):89-91.
Khan LA, Loria GR, Ramirez AS, Nicholas RA, Miles RJ, Fielder MD. (2005) Biochemical characterisation of some non fermenting, non arginine hydrolysing mycoplasmas of ruminants. Vet Microbiol 109(1-2):129-34.
Blankenberg-Sprenkels S H, Fielder M, FeltkampTE, Tiwana H, Wilson C, Ebringer A. (1998) Antibodies to Klebsiella pneumoniae in Dutch patients with ankylosing spondylitis and acute anterior uveitis and to Proteus mirabilis in rheumatoid arthritis. J Rheumatol 25:743-747.
Tani Y, Tiwana H, Hukuda S, Nishioka J, Fielder M, Wilson C, Bansal S, Ebringer A. (1997) Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis. J Rheumatol 24:109-114.
Ebringer A, Ahmadi K, Fielder M, Rashid T, Tiwana H. Wilson C, Collado A, Tani Y. (1996) Molecular mimicry: the geographical distribution of immune responses to Klebsiella in ankylosing spondylitis and its relevance to therapy. Clin Rheumatol 15:57-61.
Fielder M, Pirt S J, Tarpey I, Wilson C, Cunningham P, Ettelaie C, Binder A, Bansal S, Ebringer A. (1995) Molecular mimicry and ankylosing spondylitis: possible role of a novel sequence in pullulanase of Klebsiella pneumoniae. FEBS Lett 369:243-248.
Fielder M, Tiwana H, Youinou P, Le Goff, P, Deonarain R, Wilson C, Ebringer A. (1995) The specificity of the anti-Proteus antibody response in tissue-typed rheumatoid arthritis (RA) patients from Brest. Rheumatol Int 15:79-82.
Subair H, Tiwana H, Fielder M, Binder A, Cunningham K, Ebringer A, Wilson C, Hudson M J. (1995) Elevation in anti-Proteus antibodies in patients with rheumatoid arthritis from Bermuda and England. J Rheumatol 22:1825-1828.
Wilson C, Ebringer A, Ahmadi K, Wrigglesworth J, Tiwana H , Fielder M, Binder, A, Ettelaie C, Cunningham P, Joannou C. (1995) Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis. Ann Rheum Dis 54:216-20.
Fielder M, Lewis DJM. Mucosal Immunity and Vaccination. In Immunological Aspects of Gastroenterology. Ed. Mahida Y. Published: Springer, Edition 1, 2001
Contributor to chapter entitled: Atypical Pneumoniae. In new edition of Mycoplasmas.
Dyer R, Chowdery HS, Nagy J, Bell E, Bell P, McCabe C, Frost G, Livingstone B, Fielder MD, Jackson S. Biosciences Federation, Review of Science in the Health Service: a response to the Government office of Science. October 2007.
Professor Fielder is an experienced media spokesperson and enthusiastic science communicator. He has been widely quoted in a number of national newpapers, including The Independent and Guardian, as well as in a range of specialist publications and online news outlets. He is regularly in demand with leading broadcasters and has appeared on Sky News, Al Jazeera, BBC Radio 4's Today and PM shows and BBC World Service's Newshour programme to name but a few. He has also carried out numerous radio interviews for regional stations across the United Kingdom.
Professor Fielder is a seasoned conference speaker. He has addressed:
the MedVetNet conference on MRSA in 2006 and 2007;
various mycoplasma conferences internationally;
the Society for Applied Microbiology Zoonosis conference in 2009;
and Veterinary Laboratories Agency conferences.
Member and Honorary General Secretary of the Society for Applied Microbiology (www.sfam.org.uk).
Member of the Infectious Diseases Research Network.
Member of the Institute of Biomedical Sciences.
Member of Council for Federation of European Microbiology Societies.
Member of the International Organisation for Mycoplasmology.
In 1995, Professor Fielder was awarded the Tadion-Rideal Prize from the University of London for distinguished postdoctoral work in molecular science.